Advance Multicenter Clinical Trial: MRD-Driven Therapy in Newly Diagnosed Multiple Myeloma Patients

被引：0
|
作者：
Landgren, Ola [1 ]
Kazandjian, Dickran [2 ]
机构：
[1] Univ Miami, Sylvester Comprehens Canc Ctr, Myeloma Div, Miami, FL USA
[2] Univ Miami, Sylvester Comprehens Canc Ctr, Myeloma Div, Miami, FL USA
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-202079
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：7035 / 7036
页数：2
相关论文
共 50 条
  • [41] Clinical significance of granule-containing myeloma cells in patients with newly diagnosed multiple myeloma
    Suzuki, Kazuhito
    Yano, Shingo
    Nishiwaki, Kaichi
    Sano, Koji
    Shimada, Takaki
    Yahagi, Yuichi
    Ogasawara, Yoji
    Sugiyama, Katsuki
    Takahara, Shinobu
    Saito, Takeshi
    Kasama, Kinuyo
    Minami, Jiro
    Yokoyama, Hiroki
    Kamiyama, Yutaro
    Katsube, Atsushi
    Masuoka, Hidekazu
    Katori, Mitsuji
    Machishima, Tomohito
    Ouchi, Aya
    Dobashi, Nobuaki
    Kaito, Ken
    Usui, Noriko
    Aiba, Keisuke
    CANCER MEDICINE, 2016, 5 (11): : 3051 - 3058
  • [42] Clinical Outcomes and Evolution of Clonal Hematopoiesis in Patients with Newly Diagnosed Multiple Myeloma
    Mouhieddine, Tarek H.
    Nzerem, Chidimma
    Redd, Robert
    Dunford, Andrew
    Leventhal, Matthew
    Sklavenitis-Pistofidis, Romanos
    Tahri, Sabrin
    El-Khoury, Habib
    Steensma, David P.
    Ebert, Benjamin L.
    Soiffer, Robert J.
    Keats, Jonathan J.
    Mehr, Shaadi
    Auclair, Daniel
    Ghobrial, Irene M.
    Sperling, Adam S.
    Stewart, Chip
    Getz, Gad
    CANCER RESEARCH COMMUNICATIONS, 2023, 3 (12): : 2560 - 2571
  • [43] Phase 2 Clinical Trial of Oral Lenalidomide, Cyclophosphamide, and Prednisone (RCP) for Newly Diagnosed Multiple Myeloma Patients
    Suvannasankha, Attaya
    Farag, Sherif
    O'Bryant, Robin A.
    Wood, Lisa L.
    Abonour, Rafat
    BLOOD, 2009, 114 (22) : 1125 - 1125
  • [44] Phase 2 clinical Trial of Oral Lenalidomide, Cyclophosphamide, and prednisone (RCP) for Newly Diagnosed Multiple Myeloma Patients
    Suvannasankha, Attaya
    Farag, Sherif
    Obryant, Robin
    Wood, Lisa I.
    Porter, Nicole
    Abonour, Rafat
    BLOOD, 2010, 116 (21) : 823 - 823
  • [45] Establishing MRD Benchmark for Deployment of T-cell Redirection as Post Induction Therapy in Newly Diagnosed Multiple Myeloma
    Bal, Susan
    Magnusson, Tylan
    Ravi, Gayathri
    Giri, Smit
    Godby, Kelly
    Dhakal, Binod
    Dholaria, Bhagirathbhai
    Silbermann, Rebecca
    Callander, Natalie
    Reddy, Vishnu
    Costa, Luciano
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S133 - S134
  • [46] Impact of Continuous and Maintenance Therapy on Survival Outcome in Patients with Newly Diagnosed Multiple Myeloma: A Multicenter Retrospective Collaborative Study of the Japanese Society of Myeloma
    Ozaki, Shuji
    Handa, Hiroshi
    Saitoh, Takayuki
    Sunami, Kazutaka
    Ishida, Tadao
    Suzuki, Kenshi
    Narita, Tomoko
    Iida, Shinsuke
    Nakamura, Yuichi
    Suzuki, Kazuhito
    Nishimura, Noriko
    Murakami, Hirokazu
    Shimizu, Kazuyuki
    BLOOD, 2019, 134
  • [47] Carfilzomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed multiple myeloma: a multicenter, phase 2 study
    Bringhen, Sara
    Petrucci, Maria Teresa
    Larocca, Alessandra
    Conticello, Concetta
    Rossi, Davide
    Magarotto, Valeria
    Musto, Pellegrino
    Boccadifuoco, Luana
    Offidani, Massimo
    Omede, Paola
    Gentilini, Fabiana
    Ciccone, Giovannino
    Benevolo, Giulia
    Genuardi, Mariella
    Montefusco, Vittorio
    Oliva, Stefania
    Caravita, Tommaso
    Tacchetti, Paola
    Boccadoro, Mario
    Sonneveld, Pieter
    Palumbo, Antonio
    BLOOD, 2014, 124 (01) : 63 - 69
  • [48] The R2-ISS in a Multicenter Cohort of Chinese Patients With Newly Diagnosed Multiple Myeloma
    Yang, Peiyu
    Zhou, Fan
    Dong, Yujun
    Gao, Guangxun
    Xue, Hua
    Liang, Xinyue
    Yu, Shanshan
    Xu, Weiling
    Ma, Yanping
    Qin, Xiaoqi
    Li, Mengyao
    Dai, Yun
    Jin, Fengyan
    HEMASPHERE, 2023, 7 (04):
  • [49] Gene Expression Profiles for Molecular Classification of Multiple Myeloma in Newly Diagnosed Patients Included in a Prospective, Multicenter, Phase 3 Trial
    Broyl, A.
    Peeters, J.
    Hose, D.
    de Knegt, Y.
    Beverloo, B.
    Lokhorst, H.
    Goldschmidt, H.
    van Duin, M.
    Sonneveld, P.
    BLOOD, 2008, 112 (11) : 594 - 595
  • [50] Clonal hematopoiesis impacts frailty in newly diagnosed multiple myeloma patients: a retrospective multicenter analysis
    Gelli, Elisa
    Martinuzzi, Claudia
    Soncini, Debora
    Conticello, Concetta
    Ladisa, Francesco
    Giorgetti, Giulia
    Truffelli, Dario
    Traverso, Isabella
    Lai, Francesco
    Guolo, Fabio
    Miglino, Maurizio
    Cagnetta, Antonia
    Laudisi, Antonella
    Aquino, Sara
    Derudas, Daniele
    Di Raimondo, Francesco
    Coviello, Domenico A.
    Lemoli, Roberto M.
    Cea, Michele
    SCIENTIFIC REPORTS, 2024, 14 (01):
12345